Praecis Pharmaceuticals Inc About
Praecis Pharmaceuticals Inc PRAECIS PHARMACEUTICALS INCORPORATED
is a biopharmaceutical company focused on the discovery, development and commercialization
of innovative therapies to address significant unmet medical needs. In the United
States PRAECIS has received FDA approval to market Plenaxis® (abarelix
for injectable suspension). Two of their programs have moved beyond the
research phase and into clinical testing: Apan™ for Alzheimer's
Disease PPI-2458 for Non-Hodgkin's
Lymphoma In addition, Praecis has a number of research programs
focused on developing therapies to treat rheumatoid
arthritis, certain types of cancer, and other diseases. PRODUCT
PIPELINE PPI-2458
for Non-Hodgkin's Lymphoma/ Arthritis